Viewing Study NCT06388135


Ignite Creation Date: 2025-12-24 @ 10:40 PM
Ignite Modification Date: 2025-12-25 @ 8:11 PM
Study NCT ID: NCT06388135
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-29
First Post: 2024-04-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
Sponsor: Yang Jianjun, PhD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module